RaQualia Pharma Inc. announced consolidated financial results for the six months ended June 30, 2021. For the six months, the company announced the net sales of JPY 1,320 million as compared to JPY 372 million a year ago. Operating profit was JPY 314 million as compared to loss of JPY 403 million a year ago. Profit attributable to owners of parent was JPY 302 million as compared to loss of JPY 310 million a year ago. Basic earnings per share was JPY 14.45 as compared to loss of JPY 21.93 a year ago.